AFP and hepatocellular carcinoma: For patients with AFP elevated to > 20 ng/mL after curative treatment but negative imaging, the cumulative incidence of HCC recurrence suggested by imaging after 6 months and 1 year was 24.4% and 40.1%, respectively [58].